High-sensitivity C-reactive protein at different stages of atherosclerosis: results of the INVADE study

被引:0
作者
Carla Schulze Horn
Ruediger Ilg
Kerstin Sander
Horst Bickel
Claus Briesenick
Bernhard Hemmer
Holger Poppert
Dirk Sander
机构
[1] Klinikum rechts der Isar,Department of Psychiatry
[2] Technische Universität München,Department of Neurology
[3] Klinikum rechts der Isar,Department of Neurology
[4] Technische Universität München,undefined
[5] The Invade Study Group,undefined
[6] Medical Park Loipl,undefined
来源
Journal of Neurology | 2009年 / 256卷
关键词
High-sensitivity C-reactive protein (hsCRP); Ankle-brachial index (ABI); Intima-media thickness (IMT); Atherosclerosis; Primary prevention;
D O I
暂无
中图分类号
学科分类号
摘要
Evidence on the role of high-sensitivity C-reactive protein (hsCRP) at different stages of atherosclerosis is limited. We therefore analyzed the relationship between hsCRP and measures of subclinical and advanced atherosclerosis in a population-based sample of the INVADE study (n = 3,092, >55 years). The parameters of interest were IMT, ABI, and the stage of atherosclerosis. Differences between participants with normal and pathological hsCRP were analyzed by t test for independent samples or Fishers’ exact test. Differences of hsCRP between IMT quartiles, ABI quartiles, and different stages of atherosclerosis were analyzed by one-way ANOVA. Adjusted stepwise multiple linear regression analysis (IMT and ABI) and adjusted analysis of variance (stage of atherosclerosis) were performed, including significant baseline parameters as covariates. ANOVA showed significant differences of hsCRP among IMT quartiles, ABI quartiles, and patients with and without atherosclerosis. The adjusted analyses confirmed that the effects of IMT, ABI, and atherosclerosis on hsCRP were independent from other significant baseline parameters, but did not yield a significant difference between subclinical and advanced stages of atherosclerosis. The present analysis indicates an independent relationship between hsCRP and both IMT and ABI as measures of subclinical atherosclerosis. The comparison of subclinical and advanced stages of atherosclerosis yielded no significant difference, indicating that hsCRP is sensitive to identify vascular risk patients, but not suited to monitor progression of the disease.
引用
收藏
相关论文
共 343 条
  • [1] Bassuk SS(2004)High-sensitivity C-reactive protein. Clinical importance Curr Probl Cardiol 29 439-493
  • [2] Rifai N(2007)High-sensitivity C-reactive protein in every chart? the use of biomarkers in individual patients J Am Coll Cardiol 49 2139-2141
  • [3] Ridker PM(1995)Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) study Stroke 26 386-391
  • [4] Ben-Yehuda O(2003)C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly, the cardiovascular health study Circulation 108 166-170
  • [5] Burke GL(2004)Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid artherosclerosis Stroke 35 1619-1624
  • [6] Evans GW(2000)Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease Clin Sci (Lond) 98 531-535
  • [7] Riley WA(2006)The effect of including C-reactive protein in cardiovascular risk prediction models for women Ann Intern Med 145 21-29
  • [8] Sharrett AR(1998)Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies JAMA 279 1477-1482
  • [9] Howard G(2003)Inflammation, thrombosis and atherosclerosis: results of the Glostrup study Thromb Haemost 1 950-957
  • [10] Barnes RW(2001)C-reactive protein in ischemic stroke, an independent prognostic factor Stroke 32 917-924